Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Oncology|June 1, 2005
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantationHuseyin Abali, Basak Oyan, Yener Koc, et al.
Leukemia & Lymphoma|June 7, 2006
Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AMLSalih Aksu, Yavuz Beyazit, Ibrahim C Haznedaroglu, et al.
Leukemia & Lymphoma|December 3, 2005
Changing clinical manifestations of a T-peripheral lymphoma: from hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid massYavuz Beyazit, Ibrahim C Haznedaroglu, Salih Aksu, et al.
International Journal of Clinical Oncology|October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasisDeniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.
Hematology (Amsterdam, Netherlands)|December 18, 2014
Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemiaEylem Eliacik, Ayse Isik, Cisel Aydin, et al.
Chemotherapy|September 25, 2003
Concomitant Mycobacterium tuberculosis and Aspergillus niger infection in a patient with acute myeloid leukemiaDuygu Yazgan Aksoy, Alev Turker, M Kadri Altundag, et al.
Molecular Pharmaceutics|February 27, 2018
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 AntibodyDigdem Yoyen-Ermis, Kivilcim Ozturk, M Alper Kursunel, et al.
Anticancer Research|February 11, 2015
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in ratsNeyran Kertmen, Sercan Aksoy, Aysegul Uner, et al.
Clinical and Experimental Immunology|May 18, 2026
CD137 deficiency patients: two new patients and review of the literatureZehra Genc Ozbay, Busra Kocali, Deniz Ilgun Gurel, et al.
Cancer Immunology, Immunotherapy : CII|July 6, 2021
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytesM Alper Kursunel, Ekim Z Taskiran, Ece Tavukcuoglu, et al.
Pageof 6